NDC 0406-0357-23 - HYDROCODONE BITARTRATE AND ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0406-0357
- Requested NDC
- 0406-0357-23
- Package NDCs from labels
- 0406-0357-23
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2014-04-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS USP CIII | Physicians Total Care, Inc. | 2014-04-03 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS USP CIII | Liberty Pharmaceuticals, Inc. | 2013-09-09 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN - Medsource Pharmaceuticals | Medsource Pharmaceuticals | 2012-07-24 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN TABLETS USP CIII | STAT Rx USA LLC | PSS World Medical Inc. | 2012-01-31 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN - Contract Pharmacy Services-PA | Contract Pharmacy Services-PA | 2012-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
| HYDROCODONE BITARTRATE AND ACETAMINOPHEN - STAT RX USA LLC | STAT RX USA LLC | 2010-06-29 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-03-03 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0406-0357-01 | EA - Each | 0406-0357 | 5e99876e-18d3-4aab-bb1f-a29985e52f67 | 1 | 2012-07-24 |
| 0406-0357-05 | EA - Each | 0406-0357 | cf68f85b-0a2e-4c78-b3c5-784d4f5d751d | 1 | 2012-07-24 |
| 0406-0357-09 | EA - Each | 0406-0357 | 06374d9c-9f07-4a1a-9388-c722618ccd1b | 1 | 2012-07-24 |
| 0406-0357-23 | EA - Each | 0406-0357 | ed749a1a-614e-44a2-b052-4e92c16e8a8d | 1 | 2013-03-03 |
| 0406-0357-62 | EA - Each | 0406-0357 | a2a0c72b-664a-4de5-a43e-c3235fb5c80e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Pain Relief Extra Strength | ACETAMINOPHEN | DISCOUNT DRUG MART | e6feff0a-3347-194d-e053-2a95a90acd20 | 2024-12-05 | Warnings | 362O9ITL9D |
| Cold Plus Head Congestion Daytime | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | TopCo Associates LLC | 399e0e51-c2a7-451c-b74d-d3db140cef69 | 2024-12-05 | Warnings | 362O9ITL9D |
| Head Congestion Plus Mucus PE | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | United Natural Foods, Inc. dba UNFI | 09531edc-8dbd-451f-ae02-f922e9e8c248 | 2024-12-05 | Warnings | 362O9ITL9D |
| Pain Relief Extra Strength | ACETAMINOPHEN | DISCOUNT DRUG MART | e6fee238-0b6f-cb84-e053-2995a90a361b | 2024-12-05 | Warnings | 362O9ITL9D |
| Menstrual Complete Maximum Strength | ACETAMINOPHEN, CAFFEINE AND PYRILAMINE MALEATE | L.N.K. International, Inc. | 379ef03c-3b6a-40c3-b736-99f0537d26c8 | 2024-12-05 | Warnings | 362O9ITL9D |
| Pain Reliever Extra Strength | ACETAMINOPHEN | Marc Glassman, Inc. | 43bf297f-2832-424f-a013-4bfa1d6c03e6 | 2024-12-04 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | Precision Dose, Inc. | 5a68ab98-720c-479a-a60a-4e594add6c09 | 2024-12-04 | Warnings | 362O9ITL9D |
| COLD AND FLU DAYTIME SEVERE | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | TARGET CORP | 9de99931-31ef-79e2-e053-2a95a90a98ad | 2024-12-04 | Warnings | 362O9ITL9D |
| Migrafein FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028875c9-4129-ce2c-e063-6294a90a26cc | 2024-12-03 | Warnings | 362O9ITL9D |
| Neo-Lubrina Fuerte | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0288a327-fd4b-1991-e063-6294a90ace50 | 2024-12-03 | Warnings | 362O9ITL9D |
| CAFIZETAMOL FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028771d3-a514-f7a5-e063-6394a90ac4f3 | 2024-12-03 | Warnings | 362O9ITL9D |
| Sinus plus Headache | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | TOPCARE | a1b2b16d-c767-2945-e053-2995a90a4834 | 2024-12-03 | Warnings | 362O9ITL9D |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 048c4b03-1cf4-b724-e063-6294a90a1cad | 2024-12-03 | Warnings | 362O9ITL9D |
| Sinus Congestion and Pain Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | TopCare | fa9b2748-0474-4a39-a2b8-bb6f0678c1d1 | 2024-12-03 | Warnings | 362O9ITL9D |
| Sinus Pressure plus Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | TOPCO ASSOCIATES LLC | a9640e09-369c-3c55-e053-2a95a90aebd5 | 2024-12-03 | Warnings | 362O9ITL9D |
| Cold Max | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | TOPCO ASSOCIATES LLC | ec7e5e2e-23c7-32ae-e053-2995a90a1251 | 2024-12-03 | Warnings | 362O9ITL9D |
| COLD AND FLU SEVERE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | TOPCARE | cbb179c8-31fb-4a3a-9f23-4024350f8b7f | 2024-12-03 | Warnings | 362O9ITL9D |
| Allergy Multi Symptom | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, AND PHENYLEPHRINE HYDROCHLORIDE | TOPCO ASSOCIATES LLC | a96431a0-b05d-4812-e053-2a95a90a5af6 | 2024-12-03 | Warnings | 362O9ITL9D |
| Cold Max Nighttime | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | TopCo Associates LLC | aa0d6762-b803-4630-8f74-780b7ea9acff | 2024-12-03 | Warnings | 362O9ITL9D |
| Cold plus Head Congestion | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE | TOPCO ASSOCIATES LLC | ec7e5e2e-23c5-32ae-e053-2995a90a1251 | 2024-12-03 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.